Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer
Clinical trial NCT00415636 · COMPLETED
Trial details
- NCT number
- NCT00415636
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2010-03-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.